Trial intelligence / Profile preview

Effect of Topical Phenylephrine on EVP in Normal Eyes

NCT02965924Completed

Sponsor
Mayo Clinic
Start
Oct 2016
Primary completion
Oct 2018
Modality
Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of phenylephrine, sponsored by Mayo Clinic. Primary endpoint: Change in Episcleral Venous Pressure at 60 minutes. Started Oct 2016; status: completed.

02

Drugs

phenylephrine

Beyond the preview

Go deeper on NCT02965924.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02965924.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call